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Abstract: Equine Gastric Ulcer Syndrome (EGUS) is one of the most 
common causes of poor performance in the equine patient and affects more 
than 90% of Standardbred and Thoroughbred racehorses in training. 
Nowadays, the principal therapeutic options for EGUS treatment include 
antiacids such as histamine receptor antagonists and proton pump 
inhibitors. Recently, many studies concerning feed supplements to treat and 
prevent EGUS were carried out. The aim of the present study was to 
evaluate the efficacy of a natural feed supplement, administered for 30 
days, as the only treatment for gastric ulcerations in sport horses in 
training. Seven horses were selected for the study on the basis of their 
gastroscopic evidence of erosive and ulcerative lesions of the gastric 
mucosa. Each horse received a natural feed supplement (Gastrocure, 
Institute Farmaceutico Candioli, Italy) registered for use in horses for 30 
days. Gastroscopy was performed on day 0 (T1), day 15 (T2) and at the 
end of the treatment (day 30, T3). Scores were assigned according to 
MacAllister method (score 0,1,2,3,4 for number of lesions and score 
0,1,2,3,4,5 for lesion severity). Statistical analysis showed a strong 
evidence (p<0.01) of lower scores occurring at T3 when compared to 
T1for both number and severity of gastric lesions. In conclusion, the 
administration of Gastrocure was effective in reducing the number and 
severity of ulcerative lesions in horses affected by EGUS. 
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Introduction 
Equine Gastric Ulcer Syndrome (EGUS) is one of the 
most common causes of poor performance in the equine 
patient and affects more than 90% of Standardbred and 
Thoroughbred racehorses in training (Ferrucci et al., 
2003a; Roy et al., 2005; Bell et al., 2007). EGUS also 
affects horses involved in others disciplines such as 
endurance (Tamzali et al., 2011), show horses (White et al., 
2007) and horses not involved in competition, such as 
broodmares (Le Jeune et al., 2009). EGUS is associated 
with several risk factors, i.e., stress (Malmkvist et al., 
2012), intense training and competition (Roy et al., 2005; 
Jonsson and Egenvall, 2006) and diet (Nadeau et al., 
2003; Andrews et al., 2008). EGUS has a negative impact 
on horse’s health and performance. The most common 
clinical sings are weight loss (Murray et al., 1989; 
Dionne et al., 2003), poor performance (Nieto et al., 2009) 
and gastrointestinal symptoms (Andrews and Nadeau, 
1999; Dionne et al., 2003). EGUS treatment aims to 
promote ulcers healing, eliminate clinical signs and 
prevent the onset of recurrences (Buchanan and Andrews, 
2003). The therapeutic approach includes management 
strategies and drugs administration (Hepburn, 2001; 
Sykes and Jokisalo, 2015). The first aim of 
pharmacological therapy is to suppress acid secretion. 
Nowadays, the principal therapeutic options for EGUS 
treatment include antiacids such as histamine receptor 
antagonists andproton pump inhibitors. All these products 
are effective although a “rebound effect” is frequently 
reported and this could exacerbate the syndrome 
(Hunfeld et al., 2007) furthermore, they are expensive 
and should be administered for long periods of time. 
Besides, in sport horses, most treatments during the 
competition periodsare not permitted.These considerations 
led to an increased interest in research forless expensive 




natural alternatives to prevent the deleteriouseffects of 
increased acidity and recurrence of gastric ulcers after 
discontinuing omeprazole administration. For these 
reasons, many studies concerning feed supplementsto 
treat and prevent gastric ulceration in horses were carried 
out (Venner et al., 1999; Ferrucci et al., 2003b; Huff et al., 
2012; Hellings and Larsen 2014). 
The aim of the present study was to evaluate the 
efficacy of a natural feed supplement, administered for 
30 days, as the only treatment for gastric ulcerations in 
sport horses in training. 
Materials and Methods 
Horses 
All procedures performed on horses were approved 
by the University of Milan Ethics Committee (Protocol 
Number 72/14) and included informed owner consent. 
Seven sport horses were selected for the study on the 
basis oftheir gastroscopic evidence of erosive and 
ulcerative lesions of the gastric mucosa. The study 
population consisted in four Thoroughbreds (three mares 
and one gelding), two Standardbreds (one mare and one 
gelding) and one Arabian gelding. All horses were in full 
training either for flat (thoroughbreds and standardbreds) 
or endurance (ara bian gelding) racing. All horses ranged 
in age from three to fifteen years old (mean age: 6.6±5.5 
years) and had a mean weight of 440±34.5 kg. All the 
horses were stabled in individual boxes and bedded on 
woods having. Racehorses (thoroughbreds and 
standardbreds) were fed approximately 8 kg hay and 7 
kg commercial pelleted feed per daywith free access to 
drinking water and engaged in race once monthly. 
Endurance horse was fed 10 kg hay and 5 kg commercial 
pelletedand raced once every two month. Feeding was 
not changed in the competition period. 
Physical Examination 
A physical examination was performed on all horses 
before the beginning of the study in order to rule out the 
presence of any clinical disease. Behaviour and physical 
parameters (rectal temperature, pulse, respiratory rate, 
gut motility) were monitored at weekly intervals 
throughout the study. 
Gastroscopic Examination 
Gastroscopy was performed onday 0(T1), day 15(T2) 
and at the end ofthe treatment (day 30, T3). Before 
gastroscopic examination, feed was withheld for 24 h. 
All horses were examined with a video gastro scope 
(PV-G 34-325; Storz, Germany) connected to an 
aspirator pump (208-ACH; Faset, Italy). Horses were 
restrained with a twitch and sedated with 0.01 mg/kg i.v. 
hydrochloride detomidine (Detogesic; Zoetis, USA). To 
enable observation of the squamous mucosa, 
margoplicatus and glandular mucosa, the stomach was 
insufflate with air. Recordings of gastroscopic 
examinations were reviewed independently by three 
examiners with different level of experience. Scores 
were assigned according to MacAllister method (score 
0,1,2,3,4 for number of lesions and score 0,1,2,3,4,5 for 
lesion severity, MacAllister et al., 1997). 
Treatment 
Each horse received natural feed supplement 
(Gastrocure, Institute Farmaceutico Candioli, Italy) 
registered for use in horses (Table 1) according to the 
producer indications: 85 grams orally twice daily 
forten days and then 85 grams once daily for twenty 
days were administered. During this period, the 
management factors, such as feeding and training 
regimen, were not changed. 
Statistical Analysis 
Data were analyzed by a categorical response linear 
regression, considering the ulcer number andseverity scores 
as dependent variables. The probability for each score was 
estimated both for number and for severity. Moreover, in 
the regression model it was kept into account that each 
subject was repeatedly scored-on three occasions (times)-by 
three evaluators for each occasion. 
Time, with three increasing levels (1, 2 and 3), was 
considered as the regression independent variable. 
Both for number and severity of lesions, the 
hypothesis of higher probability of lower scores (cut 
off: ≤2), comparing T3 with T1, was tested at p<0.05 
level of significance. 
Statistical analysis was performed with SAS STAT© 
software (SAS Institute Inc., Cary, NC, USA). 
Results 
Throughout the study, the horses didnot show any signs 
of discomfort and all the monitored parameters remained 
within normal limits. The product was well accepted by all 
of the horses and no side effects were observed. 
Gastroscopy at T1 showed that all horses had gastric 
lesions localised tothe squamous mucosa close to the 
margoplicatus. Four horses had ulcers active bleeding. 
Only three horses showed lesions of the glandular 
mucosa. The average scores regarding number and 
severity of lesions of the three operators at T1, T2 and T3 
are showed in Fig. 1. 
Statistical analysis showed a strong evidence 
(p<0.01) of lower scores occurring at T3 when compared 
to T1 (Fig. 2 and 3).  
When the cut off was considered, for the number of 
lesions probability of ≤2 score increased from 0.04 to 
0.35 between time 1 and time 3 (0.31 increment) (Fig. 
4). For the severity of lesions, probability of ≤2 score 
increased from 0.36 to 0.76 between time 1 and time 3 
(0.40 increment) (Fig. 5). 




Table 1. Composition and analytical constituents of feed supplement 
Composition 
Alfalfa hay, Soybean kernel, Saccharose, Calcium Carbonate, Oils and Vegetable Fats (Soybean Oil), Magnesium Hydroxide, 
Methil-Sulphonil-Methane. 
Additives for kg: Vitamins and Pro-vitamins (Vitamin E/alpha-tocopheryl-acetate g 2,5). 
Emulsifiers and Stabilizing Agents: Guar Gum g 75. 
Natural products: Plantago ovate (Fleawort extract) g 19; Trigonellafoenum-graecum (Fenugreek extract CoE 460) g 13; Aloe Vera 
(Aloe extract CoE 28) g 6; Glycyrrhizaglabra (Licorice extract CoE 218) g 10; 
Aminoacid: L-threonine g 63;  
Preservatives: Methyl-4-hydroxibenzoate E218 g 0,23; Propile-4-hydroxibenzoate E216 g 0,12;Potassium sorbate E202 g 0,35; 
Butil-hydroxi-toluene E321 g 0,20 
Analytical constituents 
Water content 9% 
Crude protein 12% 
Crude oils and fats 7% 
Crude ashes 13% 
AshInsoluble in HCl 1% 










Fig. 2. Predicted probabilities of scores for lesion number 














Fig. 5. Predicted cumulative probabilities of scores for lesion severity 
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Fig. 6. Gastroscopic view at T1 (A) and T3 (B) of one of the horses of the study 
 
Discussion 
To date, no data reporting the efficacy of a feed 
supplement similar to the one administered in this 
study are available. The horses selected for the study 
were representative of the typical population affected by 
EGUS, i.e., high concentrates fed horses in training. 
Localisation, number and severityof the gastric lesions 
observed were consistent with previous studies 
(Ferrucci et al., 2003a; Roy et al., 2005; Bell et al.,2007; 
Tamzali et al., 2011). 
Statistical analysis showed that administration of the 
supplement reduces significantly (p<0.01) the scores for 
both number and severity of gastric lesions (Fig. 6). 
Scores improvement could be explained with the 
buffering effect of thosecomponents such as alfalfa hay 
(Husted et al., 2008), magnesium hydroxide and calcium 
carbonate (Clark et al., 1996). Besides, there are also 
other nutrients, such as threonine, Glycirrizaglabra 
(liquorice), Aloe vera, antioxidant factors and mucilages, 
that may have a protective effect on the gastric mucosa. 
Threonine is an amino acid involved in the production of 
protective mucus at the gastro-enteric level. Studies on 
piglets (Law et al., 2007) report that a lack in threonine 
represents a limiting factor for mucus 
production.Liquorice is included in the feed supplement 
in form of deglycyrrhizinated root extract, to prevent the 
occurrence of the systemic hypertension effects of 
liquorice. A study conducted in 1985 on 190 human 
patients, concluded that the substance is as effective as 
anti-acids and cimetidine in the treatment of duodenal 
chronic ulcers (Kassir, 1985). Several studies in human 
medicine and on other species proved theefficacy of 
liquorice as anti-ulcerogenic and gastro-protective factor 
(Guslandi, 1985; Aslam et al., 2015). The anti-
ulcerogenic activity of liquorice extract results in the 
suppression of acid secretion and in an increase of 
mucine secretion. Liquorice also promotes the release of 
PGE2. Antioxidant action is due to its flavonoid content 
(Khayyal et al., 2001). Besides, it was reported that 
flavonoid could inhibit protonic-pump in the glandular 
mucosa of the stomach (Beil et al., 1995). Studies 
conducted on human patients (Langmead et al., 2006) 
and on rats (Eamlamnam et al., 2006) hypothesize an 
anti-ulcerogenic activity of Aloe vera, due to its anti-
inflammatory, cytoprotective and mucus-stimulating 
effects. Anti-inflammatory effects of Aloe vera were 
demonstrated in horses as well (Lans et al., 2006). Aloe 
could act increasing the perfusion of gastric mucosa, 
reducing vasoconstriction and promoting angiogenesis, 
facilitating the healing of ulcers. Finally, mucilages 
(Pectin, Guar, Psyllium and fenugreek), when in an acid 
environment, form a viscous gel that protects the mucosa 
from the effects of acidity (Murray and Grady, 2002; 
Ferrucci et al., 2003b; Lans et al., 2006). 
One possible limit of the present study is that it was 
conducted as a field trial, in theabsence of a control 
group. This condition doesn’t allow to rule out the 
possibility that the lesions could have 
improvedspontaneously (Murray et al., 1997). However, 
the management of the horses was not changed 
throughout the study. Therefore, EGUS predisposing 
factors, such as training and competition, feeding a diet 
high in concentrates and low in fibre and box stabling 
were maintained during the whole period of treatment, 
suggesting that the administration of the supplement 
mayhave had a positive effect on ulcers healing. 
Conclusion 
In conclusion, the administration of Gastrocure was 
effective in reducing the number and severity of ulcerative 
lesions in horses affected by EGUS. These results suggest 
that this product couldbe included in the treatment 
protocol of EGUS, according to each individual case, 
either alone or as an adjuvant in anti acid treatment or 
during the period when anti acidsarediscontinued, in 
order to prevent the “rebound effect”. 
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